ALEXIS ANDERSON: Open Payments
NPI 1588395859 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 54 payments from 16 companies in 2025. Trend: 2023 $2,934 · 2024 $1,202 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $360 |
| ViiV Healthcare Company | 15 | $335 |
| Regeneron Healthcare Solutions, Inc. | 3 | $253 |
| Novo Nordisk Inc | 3 | $136 |
| Lilly USA, LLC | 6 | $129 |
| Theratechnologies Inc. | 3 | $60 |
| Amgen Inc. | 3 | $55 |
| GENZYME CORPORATION | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
Products named: DUPIXENT, Biktarvy, DOVATO, MOUNJARO, Wegovy, APRETUDE, EGRIFTA, OTEZLA.
Industry payments across MO — which companies pay providers there.
